Community/Retail

I ran into an old friend at a party the other day. I'd known him since he was about 6 and he's now in his mid-20s. For some reason, the kid had taken a shine to me.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Novo Nordisk has submitted a supplemental application to the FDA to include data from the 2 phase 3b SWITCH trials in the prescribing information for insulin degludec (Tresiba), a once-daily basal insulin that provides a duration of action beyond 42 hours for patients with type 1 and type 2 diabetes.

Traditionally, the World's Fair artistic exhibitions have incorporated elements from current scientific evolution. For example, families applied industrial science and the scientific method to everyday life in the early 20th century, so modern art emphasized reductionism in an ever more complicated world.

Meperidine: Friend or Foe?

By

Meperidine was synthetically derived in 1939 as an anticholinergic agent, but was discovered to possess analgesic properties shortly after.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how pharmacy associations work in collaboration.